In-Hospital Mortality and Hemorrhagic Risks in Traumatic Brain Injury Patients with Early vs. Late Venous Thromboembolism [0.03%]
早期与晚期静脉血栓栓塞的颅脑损伤患者的出血风险及病死率meta分析
Sophie Samuel,Jalon Barnes,Lynn Yamane et al.
Sophie Samuel et al.
Objective: This study reviewed the management and outcomes of traumatic brain injury (TBI) patients who developed venous thromboembolism (VTE) during hospitalization, focusing on the timing of VTE diagnosis and anticoagul...
HSP47 at the Crossroads of Thrombosis and Collagen Dynamics: Unlocking Therapeutic Horizons and Debates [0.03%]
HSP47在血栓和胶原动力学的交汇点：解锁治疗前景与争议
David M Smadja,Alberto F Chocron,M Marc Abreu
David M Smadja
Heat shock protein 47 (HSP47), a collagen-specific molecular chaperone encoded by the SERPINH1 gene, has emerged as a groundbreaking focus in thrombosis research. Recent findings published in "Science" have revolutionized our understanding ...
First Experiences of Patients and Healthcare Professionals with Routine Use of Patient-Reported Outcome Measures for Venous Thromboembolism [0.03%]
静脉血栓栓塞症患者报告结果测量的常规使用情况及其对患者和医护人员的影响体验首次研究
Cindy M M de Jong,Sophie N M Ter Haar,Willem Jan W Bos et al.
Cindy M M de Jong et al.
Background: Venous thromboembolism (VTE) can considerably limit patients' functioning and quality of life. Using patient-reported outcome measures (PROMs), the full impact of VTE on individual patients can be captured. ...
Compassionate Use of Osocimab in Preventing Thrombotic Complications Without Incremental Bleeding: A Case Report [0.03%]
Osocimab同情性使用预防血栓并发症而不增加出血的个案报告
Jan Beyer-Westendorf,Katrin Weber,Falk Eckart et al.
Jan Beyer-Westendorf et al.
Objective: To describe an innovative anticoagulation strategy in a 20-year-old woman with innate jejunal atresia and ultrashort bowel syndrome who was dependent on long-term parenteral nutrition and suffered from multiple...
Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis [0.03%]
血管内皮生长因子(VEGF)作为癌症相关静脉血栓形成的生物标志物的meta分析研究
Alison M Brown,Sophie Nock,Kathryn Musgrave et al.
Alison M Brown et al.
Cancer-associated thrombosis affects between 1 and 20% of all patients diagnosed with cancer and is associated with significant morbidity and a poorer prognosis. Risk assessment scores exist which include the measurement of biomarkers, and ...
Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under Flow [0.03%]
基于流动环境下血小板沉积和纤维蛋白生成测量的微流控装置快速检测血液中药物对Xa因子抑制活性
Jason M Rossi,Karen A Panckeri,Soumita Ghosh et al.
Jason M Rossi et al.
Background: Patients taking direct oral anticoagulants (DOACs) often present complicated scenarios following major bleeding, stroke, or emergency surgery. Rapid whole blood assays of DOAC levels would aid clinical decisio...
Problem Solved? An Individual Ratio between Point-of-Care and Venous International Normalized Ratio Values in Two Patients with Antiphospholipid Syndrome: Two Case Reports [0.03%]
问题解决了吗？抗磷脂综合征的两名患者的床旁与静脉采血国际标准化比率值之间的个体差异：两例病例报告
Bettina C Geertsema-Hoeve,Massimo Radin,Savino Sciascia et al.
Bettina C Geertsema-Hoeve et al.
Antiphospholipid syndrome (APS) is a rare autoimmune disorder characterized by thromboembolic and obstetric complications in the presence of persistent antiphospholipid antibodies (aPL). Treatment aims to prevent recurrent thrombosis, prima...
Risk of First Venous Thrombosis by Comparing Different Thrombin Generation Assay Conditions: Results from the MEGA Case-control Study [0.03%]
不同凝血酶生成检测条件下的首次静脉血栓风险比较：MEGA 病例对照研究结果
Kristien Winckers,Eugenia Biguzzi,Stella Thomassen et al.
Kristien Winckers et al.
Background: Hypercoagulability is a risk factor for venous thromboembolism (VTE). Thrombin generation (TG) is a global coagulation assay that measures an individual's clotting tendency. We hypothesise that slow-onset TG (...
Unwana Emagha,Khawla Yousif,Michelle Duff et al.
Unwana Emagha et al.
Rory R Koenen
Rory R Koenen